{"id":"W2105235256","doi":"10.1586/17474086.2013.827413","title":"Practical management of patients with myelofibrosis receiving ruxolitinib","year":2013,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Adverse effect; Extramedullary hematopoiesis; Anemia; Constitutional symptoms; Internal medicine; Randomized controlled trial; Clinical trial; Intensive care medicine; Bone marrow; Oncology; Disease; Haematopoiesis; Stem cell","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003480623,0.0004848287,0.0009994798,0.0009716543,0.0001901345,0.0004220763,0.0006081776,0.0006896079,0.00198457],"category_scores_gemma":[0.0006361809,0.0001273716,0.0004284238,0.0006716167,0.0001266113,0.0004726936,0.0003496305,0.0008729912,0.0008889955],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002152058,"about_ca_system_score_gemma":0.0005144819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007258391,"about_ca_topic_score_gemma":0.001898154,"domain_scores_codex":[0.9998552,0.00004453677,0.00002977536,0.0000133679,0.00004573611,0.0000113169],"domain_scores_gemma":[0.9998769,0.00004861767,0.00003377908,0.000002393938,0.00002835229,0.00001000201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009264873,0.00006209496,0.0003784326,0.01461313,0.0001284632,0.0006290535,0.00007393712,0.0002049635,0.001176734,0.0007395415,0.02399324,0.9579077],"study_design_scores_gemma":[0.0001984461,0.0002729004,0.006900835,0.01742897,0.0005780509,0.01402832,0.000303237,0.0003420145,0.001299703,0.001946828,0.956656,0.00004470046],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004612112,0.9975936,0.000190145,0.0004289865,0.00009747406,0.00001256088,0.00001872811,0.000007472709,0.001189793],"genre_scores_gemma":[0.003389095,0.9948394,0.000541714,0.0004058237,0.0001828805,0.00001678957,0.0000589511,0.000001292342,0.000563957],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00198457,"threshold_uncertainty_score":0.006639063,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04835773786757992,"score_gpt":0.3948436691014556,"score_spread":0.3464859312338757,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}